[1]黑璐宁,高晨明,刘增业.贝复舒联合玻璃酸钠滴眼液治疗干眼症的观察[J].医学信息,2020,33(03):142-143.[doi:10.3969/j.issn.1006-1959.2020.03.045]
　HEI Lu-ning,GAO Chen-ming,LIU Zeng-ye.Effect of Beifushu Combined with Sodium Hyaluronate Eye Drops in the Treatment of Xerophthalmia[J].Medical Information,2020,33(03):142-143.[doi:10.3969/j.issn.1006-1959.2020.03.045]
点击复制

贝复舒联合玻璃酸钠滴眼液治疗干眼症的观察()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年03期
页码:
142-143
栏目:
药物与临床
出版日期:
2020-02-01

文章信息/Info

Title:
Effect of Beifushu Combined with Sodium Hyaluronate Eye Drops in the Treatment of Xerophthalmia
文章编号:
1006-1959（2020）03-0142-02
作者:
黑璐宁; 高晨明; 刘增业
（天津市第一中心医院眼科，天津 300192）
Author(s):
HEI Lu-ning; GAO Chen-ming; LIU Zeng-ye
(Department of Ophthalmology,Tianjin First Central Hospital,Tianjin 300192,China)
关键词:
重组牛碱性成纤维细胞生长因子; 玻璃酸钠滴眼液; 干眼症
Keywords:
Recombinant bovine basic fibroblast growth factor; Sodium hyaluronate eye drops; Xerophthalmia
分类号:
R777
DOI:
10.3969/j.issn.1006-1959.2020.03.045
文献标志码:
A
摘要:
目的 探究重组牛碱性成纤维细胞生长因子滴眼液（贝复舒）联合玻璃酸钠滴眼液治疗干眼症的临床疗效。方法 选取2018年3月~2019年3月在我院诊治的82例干眼症患者为研究对象，采用随机数字表法分为对照组和观察组，各41例。对照组采用玻璃酸钠滴眼液治疗，观察组在对照组基础上联合应用重组牛碱性成纤维细胞生长因子滴眼液治疗，比较两组临床治疗总有效率、临床症状评分、泪膜破裂时间、泪液分泌试验、荧光素染色评分以及临床不良反应发生情况。结果 观察组治疗总有效率（95.12%）高于对照组（82.92%）（P＜0.05）；治疗后两组临床症状评分、荧光素染色评分均低于治疗前，泪膜破裂时间、泪液分泌试验均长于治疗前，且观察组优于对照组（P＜0.05）；两组均未发生严重不良反应。 结论 重组牛碱性成纤维细胞生长因子滴眼液联合玻璃酸钠滴眼液治疗干眼症有效率高，可有效改善患者临床症状，且不良反应少，用药安全，值得临床应用。
Abstract:
Objective To investigate the clinical efficacy of recombinant bovine basic fibroblast growth factor eye drops (Beifushu) combined with sodium hyaluronate eye drops in the treatment of xerophthalmia.Methods 82 patients with dry eye diagnosed and treated in our hospital from March 2018 to March 2019 were selected as the research objects, and the random number table method was used to divide them into control group and observation group, with 41 cases in each group. The control group was treated with sodium hyaluronate eye drops, and the observation group was combined with recombinant bovine basic fibroblast growth factor eye drops treatment on the basis of the control group. The clinical efficacy of the two groups, clinical symptom score, tear film rupture time, tear secretion test, and fluorescein staining were compared Score and occurrence of clinical adverse reactions.Results The total effective rate in the observation group (95.12%) was higher than that in the control group (82.92%)(P＜0.05). After treatment, the clinical symptom scores and fluorescein staining scores of the two groups were lower than those before treatment. Membrane rupture time and tear secretion test were longer than before treatment, and the observation group was better than the control group(P＜0.05); no serious adverse reactions occurred in both groups.Conclusion Recombinant bovine basic fibroblast growth factor eye drops combined with sodium hyaluronate eye drops is effective in treating xerophthalmia, and can effectively improve the clinical symptoms of patients with fewer adverse reactions and safe medication, which is worthy of clinical application.

参考文献/References:

[1]田莉,吴永红.玻璃酸钠滴眼液联合贝复舒对干眼症患者症状改善情况的影响研究[J].中国全科医学,2017(S2):169-171. [2]高海艳.普拉洛芬联合玻璃酸钠治疗干眼症疗效观察[J].中国医药科学,2014,2(23):72-73. [3]郑琦,向金明,温静君,等.普拉洛芬联合玻璃酸钠治疗干眼症临床观察[J].山东大学学报(医学版)2014,52(2):117-118. [4]付学玲,江颖,赵晓霞,等.芪明颗粒联合普拉洛芬滴眼液治疗糖尿病超乳术后干眼并角膜上皮损伤59例[J].中国药业,2014,21(24):116－117 [5]涂雪峰.重组牛碱性成纤维细胞生长因子联合玻璃酸钠治疗干眼症的疗效分析[J].山东大学耳鼻喉眼学报,2018,32(6):90-93.

相似文献/References:

[1]刘新红,李铭杰.重组牛碱性成纤维细胞生长因子联合高压氧对肛肠病术后创面愈合的影响[J].医学信息,2020,33(14):151.[doi:10.3969/j.issn.1006-1959.2020.14.047]
　LIU Xin-hong,LI Ming-jie.Effect of Recombinant Bovine Basic Fibroblast Growth Factor Combined with Hyperbaric Oxygen on Wound Healing after Anorectal Disease[J].Medical Information,2020,33(03):151.[doi:10.3969/j.issn.1006-1959.2020.14.047]
[2]方良华.外用重组牛碱性成纤维细胞生长因子凝胶治疗颌面部软组织擦伤的临床疗效[J].医学信息,2023,36(10):165.[doi:10.3969/j.issn.1006-1959.2023.10.037]
　FANG Liang-hua.Clinical Efficacy of Recombinant Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Maxillofacial Soft Tissue Abrasion[J].Medical Information,2023,36(03):165.[doi:10.3969/j.issn.1006-1959.2023.10.037]

更新日期/Last Update: 2020-02-01